Jalli, Sandeep
Strepkos, Dimitrios
Alexandrou, Michaella
Mutlu, Deniz
Carvalho, Pedro E. P.
Kladou, Eleni
Ser, Ozgur S.
Singh Sara, Jaskanwal Deep
Mastrodemos, Olga
Rangan, Bavana V.
Voudris, Konstantinos
Burke, M. Nicholas
Sandoval, Yader
Brilakis, Emmanouil S.
Article History
Received: 27 June 2025
Accepted: 6 October 2025
First Online: 23 October 2025
Declarations
:
: All studies with human or animal subjects are published and followed ethical standards.
: Dr. Sandoval: Dr. Sandoval reports the following disclosures: Abbott (consultant, advisory board), Roche Diagnostics (consultant, advisory board, speaker), Philips (consultant, advisory board, speaker), Zoll (advisory board), GE Healthcare (consultant, advisory board), CathWorks (consultant), HeartFlow (speaker), Cleerly (speaker, research grant). He is an Associate Editor for JACC Advances. He and others hold patent 20210401347. Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), Cordis, CSI, Elsevier, GE Healthcare, Haemonetics, IMDS, Medtronic, SIS Medical, Teleflex, and Orbus Neich; research support: Boston Scientific, GE Healthcare; owner, Hippocrates LLC; shareholder: LifeLens Technologies, Inc, MHI Ventures, Cleerly Health, Stallion Medical, TrueVue Inc. The rest of the authors have no relevant disclosures.
: The authors declare no competing interests.